Navigation Links
Five AIDS Patients To Receive Experimental Anti-retroviral Drugs

A group of five AIDS victims who have been trying to gain special access to the much sought unapproved anti- HIV drugs (TMC 114 and TMC 125) can now rejoice as the Health Canada // has now issued the medication in what can be considered as a rare clinical trial.

Dr. Montaner, an AIDS drugs specialist with the B.C. Centre for Excellence in HIV/AIDS at St. Paul's Hospital has been trying hard to bring the two unapproved drugs into Canada as a special case. He had even submitted an application to Health Canada in this regard. A special access program that is designed to get unapproved drugs to terminally ill patients was his only hope.

"We started nine months ago looking for treatment. In that time, unfortunately, one [of the six men] has died. We need to make sure we do the best for the patients at all times and not get hung up on unnecessary bureaucratic delays," said Montaner.

Health Canada however refused the request on grounds of inadequate data regarding the synergistic effect of the two drugs. Following this, the doctor and his team sought the help of media and politicians. Unable to withstand the pressure, it has been decided to provide the patients with the drug under a unique approach, a clinical trial.

The chair of St. Paul's ethical-review board that approved the protocol has requested for minor changes to be incorporated in the patient consent forms. The clinical trail is believed to ensure better monitoring of the five patients. A contract would soon by signed between the hospital and the drug supplier, Tibotec Inc., which has agreed to provide the drug free of cost.

The drug is hoped to reach the patients in the coming year. One of the proposed recipient, B.C. artist Tiko Kerr has expressed his feelings of joy following the announcement. He his nervous system has already been affected. Infact he has already lost sensation in his feet and one hand. He manages to do painting with the other hand in which th ere is some sensation preserved.

Health Minister Ujjal Dosanjh has also been very active in ensuring drug supply to the victims. He met another patient, Paul Lewand, chairman of the B.C. Persons with AIDS Society. While the whole world visualises a hopeless end for AIDS victims, this move is expected to infuse an endless hope amongst the five victims.
'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... ... 08, 2016 , ... Healthcare is in flux. The GOP ... the mass media launching of story movements to highlight what's most unfair about ... experiences; such a movement can generate the network power to improve healthcare policies ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
Breaking Medicine Technology: